The Patent Finder

D. Collen Research Foundation VZW

Also on record
Records under this name other than patents D. Collen Research Foundation VZW holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to D. Collen Research Foundation VZW

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,357,929Placental growth factor as a target for the treatment of osteoporosis
Formerly held
Term ended
Term ended Jun 27, 2023 · USPTO record
Term endedTerm ended Jun 27, 2023USPTO record
US 7,875,704Novel Anti-Plgf Antibody
Formerly held
Lapsed on the fee record
Ended Jan 25, 2023 · High confidence
Lapsed on the fee recordEnded Jan 25, 2023High confidence
US 7,482,004Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage
Formerly held
Term ended
Term ended Mar 21, 2022 · USPTO record
Term endedTerm ended Mar 21, 2022USPTO record
US 7,226,908Use of VEGF and homologues to treat neuron disorders
Formerly held
Lapsed on the fee record
Ended Jun 5, 2019 · USPTO record
Lapsed on the fee recordEnded Jun 5, 2019USPTO record
US 7,863,246Treatment of amyotrophic lateral sclerosis
Formerly held
Lapsed on the fee record
Ended Jan 4, 2019 · USPTO record
Lapsed on the fee recordEnded Jan 4, 2019USPTO record
US 7,829,085Methods of treating hemostasis disorders using antibodies binding the C1 domain of factor VIII
Formerly held
Lapsed on the fee record
Ended Nov 9, 2018 · USPTO record
Lapsed on the fee recordEnded Nov 9, 2018USPTO record
US 7,105,168Method of improving ischemic muscle function by administering placental growth factor
Lapsed on the fee record
Ended Sep 12, 2018 · USPTO record
Lapsed on the fee recordEnded Sep 12, 2018USPTO record
US 7,785,594Factor VIII inhibitory antibodies with reduced glycosylation
Formerly held
Lapsed on the fee record
Ended Aug 31, 2018 · USPTO record
Lapsed on the fee recordEnded Aug 31, 2018USPTO record
US 8,784,816Antibodies which bind factor VIII
Formerly held
Lapsed on the fee record
Ended Jul 22, 2018 · USPTO record
Lapsed on the fee recordEnded Jul 22, 2018USPTO record
US 7,067,313Ligands for use in therapeutic compositions for the treatment of hemostasis disorders
Formerly held
Lapsed on the fee record
Ended Jun 27, 2018 · USPTO record
Lapsed on the fee recordEnded Jun 27, 2018USPTO record
10 of 24 patents shown.
Pro members see all 24.
Pro members: see all 24 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited